Investigation of ABCA1 C69T and G-191C polymorphisms in coronary artery disease

In Vivo

Volumn 22, Issue 2, 2008, Pages 187-190

  Ergen, Arzu ^a   Isbir, Selim ^b   Tekeli, Atike ^a   Isbir, Turgay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

ABCA1; Cholesterol; Coronary artery disease; Genetic; Lipoproteins; Polymorphism; VLDL

Indexed keywords

ABC TRANSPORTER A1; CYTOSINE; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYMINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 42149083936     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tarchalski J, Guzik P and Wysocki H: Correlation between the extent of coronary atherosclerosis and lipid profile. Mol Cell Biochem 246(1-2): 25-30, 2003.
2. Rader DJ: High-density lipoproteins and atherosclerosis. Am J Cardiol 90(8A): 62i-70i, 2002.
3. Nordestgaard HG, Benn M, Schnohr P and Tybjaerg-Hansen A: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298(3): 299-308, 2007.
4. Goldbourt U, Yaari S and Medalie JH: Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 17(1): 107-113, 1997.
5. Dean M, Rzhetsky A and Allikmets R: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11(7): 1156-1166, 2001.
6. Huang W, Moriyama K, Koga T, Hua H, Ageta M, Kawabata S, Mawatari K, Imamura T, Eto T, Kawamura M, Teramoto T and Sasaki J: Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary artery disease. Biochim Biophys Acta 1537: 71-78, 2001.
7. Pisciotta L, Hamilton-Craig I, Tarugi P, Bellocchio A, Fasano T, Alessandrini P, Bon GB, Siepi D, Mannarino E, Cattin L, Averna M, Cefalù AB, Cantafora A, Calandra S and Bertolini S: Familial HDL deficiency due to ABCA1 gene mutations with or without othar genetic lipoprotein disorders. Atherosclerosis 172: 309-320, 2004.
8. Zwarts KY, Clee SM, Zwinderman AH, Engert JC, Singaraja R, Loubser O, James E, Roomp K, Hudson TJ, Jukema JW, Kastelein JJ and Hayden MR: ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 61: 115-125, 2002.
9. Stefkova J, Poledne R and Hubacek JA: Polymorphisms in ABCA1 transporter and plasma lipids. Physiol Res 53: p3, 2004.
10. Sheǐdina AM, Pchelina SN, Demidova DV, Rodygina TI, Taraskina AE, Toperverg OB, Berkovich OA, Demina EV, Shvarts EI, Pogoda TV, Generozov EV, Govorun VM, Lopukhin IuM and Shevchenko IuA: Allele frequency analysis of four single nucleotide polymorphisms locating in promoter and 5′-untranslated regions of ABCA1 gene in young men - survivors from myocardial infarction. Kardiologiia 44(8): 40-45, 2004 (in Russian).
11. Albrecht C, Soumian S, Amey JS, Sardini A, Higgins CF, Davies AH and Gibbs RG: ABCA1 Expression in Carotid Atherosclerotic Plaques. Stroke 35: 2801-2806, 2004.
12. Martin M, Gonzalez P, Reguero JJR, Batalla A, Castro MG, Coto E and Moris C: ABCA1 polymorphisms and prognosis after myocardial infarction in young patients. Int J Cardiol 110: 267-268, 2006.
13. Friedewald, WT, Levy RI and Fredrickson DS: Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-508, 1972.
14. Miller SA, Dykes DD and Polesky HS: Simples salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16(3): 1215, 1988.
15. Oram JF: Tangier disease and ABCA1. Biochim Biophys Acta 1529: 321-330, 2000.
16. Mahley RW, Palaoǧlu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F, Ozbayrakci S, Gokdemir O and Winkler W: Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 36: 839-859, 1995.
17. Jensen MK, Pai JK, Mukamale KJ, Overvad K and Rimm EH: Common genetic variation in the ATP-binding cassette transporter A1, plasma lipids, and risk of coronary heart disease. Atherosclerosis 195(1): 172-180, 2007.
18. Hong SH, Riley W, Rhyne J, Friel G and Miller M: Lack of association between increased carotid intima-media thickening and decreased HDL-cholesterol in a family with a novel ABCA1 variant, G2265T. Clin Chem 48(11): 2066-2070, 2002.
19. Liu L, Guo ZG, Wang QG, Liu SL, Lai WY and Tu Y: Significance of -191G/C single nucleotide polymorphisms in the promoter region of ATP binding cassette transporter gene in coronary artery disease. J First Mil Med Univ 25(6): 660-662, 2005.
20. Hodoglugil U, Williamson DW, Huaung Y and Mahley RW: Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein levels in Turks. Atherosclerosis 183(2): 199-212, 2005.
21. Mantaring M, Rhyne J, Hong SH and Miller M: Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype. Translational Research 149: 205-210, 2007.
22. Wu Y, Bai H, Liu R, Liu Y and Liu B: Analysis of ATP binding cassette A1 gene R219K polymorphism in patients with endogenous hypertriglyceridemia in Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24(2): 177-181, 2007 (in Chinese).